Keros Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of KROS for the last quarter is 83.00 k USD, and it's 41.96% lower compared to the previous quarter. The net income of Q1 24 is -43.11 M USD.